Current Status: Carbonic Anhydrase Inhibitors as Potential Alzheimer consequences
Clicks: 1
ID: 311276
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #23 of 34 articles by views in Journal of Clinical Advances and Research Reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Alzheimer's illness (Promotion) is a neurodegenerative problem and a vital premise of dementia in the old populace worldwide. As of late, human carbonic anhydrases were exhibited as conceivable new focuses for treating Promotion. Expansion in the occurrence of neurodegenerative illnesses, specifically Alzheimer's Sickness (Promotion), is a result of the world′s populace maturing yet sadly, existing therapies are just compelling at deferring a portion of the side effects and temporarily. Regardless of enormous endeavors by both scholarly analysts and drug organizations, no illness adjusting drugs have been brought to the market somewhat recently. As of late, a few examinations shed light on Carbonic Anhydrases as conceivable new focuses for Promotion treatment. In the current survey we summed up preclinical and clinical discoveries with respect to the job of CAs and their inhibitors/activators on cognizance, maturing and neurodegeneration and we examine future difficulties and open doors in the field.
| Reference Key |
imported_1770374321_6985c4b18ebf8
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Triloki Prasad*, Mohd. Shauib, Rohit Kumar, Deepak Kushwaha, Pradip Kumar, Preeti, Ambika Shakya, Vivek Kushwaha |
| Journal | Journal of Clinical Advances and Research Reviews |
| Year | 2024 |
| DOI |
10.62896/jcarr.v1.i3.04
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.